News | Breast Imaging | August 02, 2019

Volpara to Distribute Screenpoint Medical's Transpara AI Solution

Volpara will sell artificial intelligence-powered breast cancer detection solution in the U.S., Australia, New Zealand and parts of Asia

Volpara to Distribute Screenpoint Medical's Transpara AI Solution

August 2, 2019 — Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara products to breast imaging clinics in the United States, Australia, New Zealand and parts of Asia. Transpara is designed to assist radiologists with the reading of mammograms and is one of the first next-generation artificial intelligence (AI) applications for detecting breast cancer in screening mammograms to gain 510(k) clearance from the U.S. Food & Drug Administration (FDA).

FDA clearance was supported by the results of a multi-reader, multi-case reader study published in February 2019 in Radiology, which demonstrated that radiologists using Transpara significantly improved detection accuracy without increasing reading times.1 Radiologists' performance consistently improved independent of their level of experience. In the JNCI publication that followed in March, it was reported that when compared to 101 radiologists, the stand-alone performance (sensitivity and specificity) of Transpara was as accurate.2 This suggests that the system gives an objective second opinion similar to that of a second radiologist. 

Transpara gained European regulatory approval (CE) for use with multi-vendor mammography (2018) and digital breast tomosynthesis (DBT) images (2019), and is already installed at breast imaging centers in Europe.

Both companies showcased their complete suite of breast imaging analytics tools at the Association for Medical Imaging Management (AHRA) 2019 Annual Meeting, July 21-24 in Denver.

For more information:,


1. Rodriguez-Ruiz A., Krupinski E., Mordang J., et al. Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System. Radiology, published online Nov. 20, 2018.

2. Rodriguez-Ruiz A., Lang K., Gubern-Merida A., et al. Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists. Journal of the National Cancer Institute, March 5, 2019.

Related Content

Dicom Systems Receives U.S. Patent for Medical Data Integration Engine
News | Enterprise Imaging | October 22, 2019
Dicom Systems announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent 10,437,877 B2 to...
Carestream's Focus 35C digital radiography (DR) detector

The Focus 35C detector. Image courtesy of Carestream

News | Digital Radiography (DR) | October 22, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA), Dec. 1-6 in Chicago, Carestream will...
Major Radiology Organizations Publish Ethics of AI in Radiology Statement
News | Artificial Intelligence | October 22, 2019
Experts in the use of artificial intelligence (AI) in radiology, from many of the world’s leading radiology, medical...
GE Healthcare and Premier Inc. Developing One-stop Breast Clinic Model for U.S.
News | Mammography | October 21, 2019
GE Healthcare and Premier Inc. have announced a collaboration to develop a model to bring a same-day breast cancer...
Laurel Bridge Software Celebrates 20th Anniversary
News | Enterprise Imaging | October 21, 2019
Laurel Bridge Software recently celebrated its 20th anniversary of helping healthcare providers and original equipment...
Densitas Breast Density Assessment Software Joins Nuance AI Marketplace
News | Breast Density | October 21, 2019
Densitas Inc. announced that its U.S. Food and Drug Administration (FDA)-cleared densitas densityai breast density...
FDA Clears AiCE Image Reconstruction on Canon's Aquilion Precision CT

Image courtesy of Canon Medical Systems

Technology | Computed Tomography (CT) | October 21, 2019
Canon Medical Systems USA Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance on its Advanced...
The Revolution Apex intelligent computed tomography (CT) scanner

The Revolution Apex intelligent computed tomography (CT) scanner. Image courtesy of GE Healthcare.

News | RSNA | October 18, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA 2019), Dec. 1-6 in Chicago, GE Healthcare...
Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers
Feature | Artificial Intelligence | October 18, 2019 | Sanjay Parekh, Ph.D.
October 18, 2019 — As the nascent market for...